JP2007522094A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522094A5
JP2007522094A5 JP2006527154A JP2006527154A JP2007522094A5 JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5 JP 2006527154 A JP2006527154 A JP 2006527154A JP 2006527154 A JP2006527154 A JP 2006527154A JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5
Authority
JP
Japan
Prior art keywords
kinase
drug
hexokinase
complex
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006527154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522094A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/031147 external-priority patent/WO2005030258A2/en
Publication of JP2007522094A publication Critical patent/JP2007522094A/ja
Publication of JP2007522094A5 publication Critical patent/JP2007522094A5/ja
Abandoned legal-status Critical Current

Links

JP2006527154A 2003-09-22 2004-09-22 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法 Abandoned JP2007522094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50532503P 2003-09-22 2003-09-22
US58183504P 2004-06-22 2004-06-22
PCT/US2004/031147 WO2005030258A2 (en) 2003-09-22 2004-09-22 Small molecule compositions and methods for increasing drug efficiency using compositions thereof

Publications (2)

Publication Number Publication Date
JP2007522094A JP2007522094A (ja) 2007-08-09
JP2007522094A5 true JP2007522094A5 (es) 2007-12-06

Family

ID=34396244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006527154A Abandoned JP2007522094A (ja) 2003-09-22 2004-09-22 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法

Country Status (5)

Country Link
EP (1) EP1689439A2 (es)
JP (1) JP2007522094A (es)
AU (1) AU2004275770A1 (es)
CA (1) CA2539914A1 (es)
WO (1) WO2005030258A2 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
KR20030036189A (ko) 2000-05-26 2003-05-09 이데닉스(케이만)리미티드 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물
KR20050088079A (ko) 2002-11-15 2005-09-01 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
US8138361B2 (en) 2005-12-28 2012-03-20 The Trustees Of The University Of Pennsylvania C-10 carbamates of taxanes
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
CN102105135B (zh) * 2008-05-23 2016-08-24 英属哥伦比亚大学 用于脂质体纳米颗粒的修饰的药物
EP2318832B1 (en) 2008-07-15 2013-10-09 Academia Sinica Glycan arrays on ptfe-like aluminum coated glass slides and related methods
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
US9556216B2 (en) 2012-08-31 2017-01-31 Novartis Ag 2′-Ethynyl nucleoside derivatives for treatment of viral infections
CA2891125A1 (en) 2012-11-19 2014-05-22 Merck Sharp & Dohme Corp. 2 -alkynyl substituted nucleoside derivatives for treating viral diseases
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
US9782476B2 (en) 2013-09-06 2017-10-10 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
JP2017507118A (ja) 2014-01-16 2017-03-16 アカデミア シニカAcademia Sinica がんの処置および検出のための組成物および方法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TWI687428B (zh) 2014-03-27 2020-03-11 中央研究院 反應性標記化合物及其用途
EP3149045B1 (en) 2014-05-27 2023-01-18 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102512592B1 (ko) 2014-05-27 2023-03-21 아카데미아 시니카 항-her2 글리코항체 및 이의 용도
CA2950415A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-tnf-알파 글리코항체 및 이의 용도
KR102422375B1 (ko) 2014-09-08 2022-07-18 아카데미아 시니카 당지질을 사용한 인간 iNKT 세포 활성화
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
EP3248005B1 (en) 2015-01-24 2020-12-09 Academia Sinica Novel glycan conjugates and methods of use thereof
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカAcademia Sinica N−グリカンおよびそのアレイのモジュール合成のための方法
CN109963868B (zh) 2016-08-22 2023-11-14 醣基生医股份有限公司 抗体、结合片段及使用方法
KR20210021984A (ko) * 2018-05-15 2021-03-02 인터크 펩타이드 테라퓨틱스 리미티드 펩타이드 활성화 제제
AU2019268411B2 (en) * 2018-05-15 2024-03-14 Interk Peptide Therapeutics Limited Activating agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59083A (en) * 1979-01-10 1983-12-30 Israel Marcus Pharmaceutical composition containing thymidine and a salicyclic acid derivative as a solubilizing agent therefor
US5608049A (en) * 1995-03-10 1997-03-04 Bristol-Myers Squibb Company Preparation of d4T from 5-methyluridine
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds

Similar Documents

Publication Publication Date Title
JP2007522094A5 (es)
JP2007169302A5 (es)
JP2007520565A5 (es)
JP2004516265A5 (es)
JP2003503454A5 (es)
DE602004017510D1 (de) Medizinprodukt vom kapseltyp
ZA200704661B (en) Solid, orally appliance pharmaceutical administration forms containing rivaroxaban having modified release
JP2009524695A5 (es)
NO332405B1 (no) Forbindelse av 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling, deres anvendelse til fremstilling av farmasoytiske midler for behandling av inflammatorisk sykdom og farmasoytisk preparat omfattende forbindelsen.
WO2006095029A3 (en) Di-polymer protein conjugates and processes for their preparation
WO2007144169A3 (en) Entacapone-derivatives
PT1718340E (pt) Novos conjugados de efectores, processo para a sua produção e sua utilização farmacêutica
JP2008519810A5 (es)
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
JP2009536193A5 (es)
WO2007144699A3 (en) Process for the preparation of alfuzosin
EP1996732A4 (en) RECOGNITION AND TREATMENT AND DISCOVERY OF REMEDIES AGAINST MYCOBACTERIAL DISEASES
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
IL184487A0 (en) N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application
FR2912404B1 (fr) Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
ATE430748T1 (de) Imidazo (1,2-a)pyridin-3-ylessigsäurehydrazide, herstellungsverfahren dafür und pharmazeutische verwendungen davon
JP2011528230A5 (es)